Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
B-cell Lymphoma
100%
Complete Remission
10%
Diffuse Large B-cell Lymphoma (DLBCL)
10%
Follow-up Data
10%
Follow-up Interval
10%
Graft-versus-host Disease (GvHD)
20%
High Risk
20%
Marrow Transplantation
10%
Multivariable
10%
Non-relapse Mortality
10%
Overall Survival
40%
Progression-free Survival
10%
Relapsed Disease
20%
Relapsed or Refractory
10%
Remission
10%
Retrospective Observational Study
10%
Taiwan
100%
Therapeutic Potential
10%
Transplantation
10%
Medicine and Dentistry
Allogeneic Hematopoietic Stem Cell Transplantation
100%
Autologous Stem Cell Transplantation
25%
B-Cell Lymphoma
100%
Diffuse Large B-Cell Lymphoma
12%
Diseases
25%
Graft Versus Host Reaction
25%
Infection
12%
Non-Relapse Mortality
12%
Observational Study
12%
Overall Survival
50%
Progression Free Survival
12%
Immunology and Microbiology
Allogeneic Hematopoietic Stem Cell Transplantation
100%
Autologous Stem Cell Transplantation
25%
B Cell
100%
Graft-Versus-Host Disease
25%
Overall Survival
50%
Progression Free Survival
12%